Medication info
BC Atorvastatin Tablets (Atorvastatin Calcium Hydrate)

BC Atorvastatin Tablets (Atorvastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Hydrate›10.85mg / 1 tablet
Manufacturer / importer
BC World Pharma Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200705819 · Notified 2007.05.21 · Insurance code 653100600

Summary

Main use
Improvement of hyperlipidemia (e.g., familial hypercholesterolemia in children) and prevention of cardiovascular disease (e.g., myocardial infarction)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.
Child dose
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Ingredients

Manufacturer
BC World Pharma Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (e.g., familial hypercholesterolemia in children) and prevention of cardiovascular disease (e.g., myocardial infarction)

  • Myocardial infarction
  • stroke
  • vascular intervention
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication decreases the risk of myocardial infarction and stroke in adults with various risk factors for coronary artery heart disease and patients with type 2 diabetes, and reduces the risk related to vascular interventions and angina. Moreover, it significantly reduces the risk of fatal and non-fatal myocardial infarction, stroke, and hospitalization due to congestive heart failure in patients with clinically evident coronary artery heart disease, thereby improving overall cardiovascular health. This drug helps lower total cholesterol, LDL cholesterol, Apo-B protein, and triglycerides while increasing HDL cholesterol in patients with primary hypercholesterolemia and various dyslipidemias. It can be used in combination with or as an alternative to other treatments in patients with hyperlipidemia that are not controlled by diet alone, or in patients with homozygous familial hypercholesterolemia. In pediatric patients with heterozygous familial hypercholesterolemia, this medication may be used as an adjunct to reduce the risk of cardiovascular disease. Overall, this medication is used to reduce the risks associated with cardiovascular disease and hyperlipidemia and to improve cardiovascular health by managing blood lipid levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dosage range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into consideration treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when starting treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia The dosage of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the adult patient population.

Child dose

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years of age): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle problems; if symptoms of muscle pain or weakness occur, discontinue use immediately and consult a physician. Do not take this medication if you have certain liver diseases or extremely high liver function test results. It is not to be administered to patients with muscle disorders, women who are pregnant, children under the age of 10, or patients taking certain medications. Patients with a history of alcohol abuse or liver disease should use this medication with caution, and if there is a risk of muscle-related disorders, muscle enzyme levels should be checked before treatment. While this medication is generally well tolerated, rare side effects such as liver function abnormalities, muscle pain, indigestion, headache, allergic reactions can occur. Regular liver function and muscle enzyme tests should be performed while taking this medication, and any unusual symptoms should be reported to a physician immediately. This medication can interact with other drugs, so inform your physician or pharmacist of any other medications being taken. Particular care should be taken when used in conjunction with specific antibiotics, antifungals, antivirals, immunosuppressants, grapefruit juice, etc. Women who are pregnant or breastfeeding should not take this medication, and fertile women should use appropriate contraceptive methods during treatment. The elderly or patients with impaired kidney function are at a greater risk for muscle damage and should exercise additional caution. In case of overdose, there is no specific antidote, and treatment should be symptomatic. Keep out of reach of children.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 145 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • nosebleed
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disturbance
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • ruptured complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • liver function test abnormalities
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased butyrylcholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • erectile dysfunction
  • urinary tract infection
  • increased urinary frequency
  • cystitis
  • hematuria
  • dysuria
  • renal stones
  • nocturia
  • epididymitis
  • breast fibrocystic change
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • colored urine
  • neurogenic edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • taste disturbance
  • taste loss
  • dysgeusia
  • itching
  • rash
  • alopecia
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcerations
  • sweating
  • acne
  • urticaria
  • eczema
  • seborrhea
  • skin ulcerations
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • cognitive impairment
  • myasthenia gravis
  • ocular myasthenia
  • fulminant hepatitis
  • nausea
  • vomiting
  • lethargy
  • liver function abnormalities
  • jaundice
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • erythema multiforme

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best to maintain a temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.